Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …

Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …

To overcome problems associated with topical delivery of tacrolimus (TCS), a
thermoresponsive in situ gel system containing pluronic F127 (PL), and chitosan (CS) was …

Damage to the retinal pigment epithelium, Bruch's membrane and/or tissues underlying
macula is known to increase the risk of age-related macular degeneration (AMD). AMD is …

Glaucoma is known to be one of the principal causes of vision loss due to elevated
intraocular pressure. Currently, latanoprost eye drops is used as first-line treatment for …

Age-related macular degeneration (AMD), a degenerative eye disease, is the major cause of
irreversible loss of vision among individuals aged 50 and older. Both genetic and …

As an indispensable part of the human sensory system, visual acuity may be impaired and
even develop into irreversible blindness due to various ocular pathologies. Among ocular …

Docetaxel (DTX) is classified as a class IV drug that exhibits poor aqueous solubility (6–7
µg/mL in water) and permeability (P-glycoprotein substrate). The main objective of this study …

Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading
cause of irreversible vision loss in people 50 years and older. Today, the most common …

Tacrolimus, in spite of its good safety profile with fewer adverse effects (when treated locally)
is still being used as an off-label drug to treat ocular diseases-like corneal graft-versus-host …